BRIEF-MHRA's Yellow Card Biobank To Probe Genetic Influence On Acute Pancreatitis Risk From GLP-1 Injections

Reuters
26 Jun
BRIEF-MHRA's Yellow Card Biobank To Probe Genetic Influence On Acute Pancreatitis Risk From GLP-1 Injections

June 26 (Reuters) - UK's MHRA:

  • UK'S MHRA: YELLOW CARD BIOBANK TO PROBE IF RISK OF ACUTE PANCREATITIS FROM GLP-1 INJECTIONS MAY BE INFLUENCED BY AN INDIVIDUAL’S GENES - WEBSITE

  • UK'S MHRA: PATIENTS HOSPITALISED WITH ACUTE PANCREATITIS SUSPECTED TO BE RELATED TO GLP-1 MEDICINES BEING ASKED TO REPORT IT TO YELLOW CARD SCHEME

Further company coverage: LLY.N

((Reuters.Briefs@thomsonreuters.com;;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10